59Z Stock Overview
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
My Notes
Capture your thoughts, links and company narrative
MediPal Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥14.30 |
| 52 Week High | JP¥16.90 |
| 52 Week Low | JP¥12.90 |
| Beta | 0.12 |
| 1 Month Change | 0.70% |
| 3 Month Change | 1.42% |
| 1 Year Change | -1.38% |
| 3 Year Change | -11.98% |
| 5 Year Change | n/a |
| Change since IPO | -13.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| 59Z | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 2.9% | 1.8% | 2.0% |
| 1Y | -1.4% | 38.5% | 15.2% |
Return vs Industry: 59Z underperformed the German Healthcare industry which returned 38.5% over the past year.
Return vs Market: 59Z underperformed the German Market which returned 15.2% over the past year.
Price Volatility
| 59Z volatility | |
|---|---|
| 59Z Average Weekly Movement | 3.1% |
| Healthcare Industry Average Movement | 4.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 59Z has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 59Z's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1898 | 13,075 | Shuichi Watanabe | www.medipal.co.jp |
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products.
MediPal Holdings Corporation Fundamentals Summary
| 59Z fundamental statistics | |
|---|---|
| Market cap | €3.02b |
| Earnings (TTM) | €286.44m |
| Revenue (TTM) | €22.42b |
10.5x
P/E Ratio0.1x
P/S RatioIs 59Z overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 59Z income statement (TTM) | |
|---|---|
| Revenue | JP¥3.60t |
| Cost of Revenue | JP¥3.35t |
| Gross Profit | JP¥251.72b |
| Other Expenses | JP¥205.67b |
| Earnings | JP¥46.05b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 10, 2025
| Earnings per share (EPS) | 221.43 |
| Gross Margin | 6.98% |
| Net Profit Margin | 1.28% |
| Debt/Equity Ratio | 0% |
How did 59Z perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield27%
Payout RatioDoes 59Z pay a reliable dividends?
See 59Z dividend history and benchmarks| MediPal Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 04 2025 |
| Days until Ex dividend | 55 days |
| Days until Dividend pay date | 123 days |
Does 59Z pay a reliable dividends?
See 59Z dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 02:10 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MediPal Holdings Corporation is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Atsushi Seki | Barclays |
| Ritsuo Watanabe | BofA Global Research |
| Hidemaru Yamaguchi | Citigroup Global Markets Japan Inc. |